NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.20
-0.42 (-4.37%)
Mar 31, 2025, 9:53 AM EDT - Market open
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$300,257
Profits / Employee
-$35,785
Market Cap
1.18B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 21 days ago - NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline - Business Wire
- 4 weeks ago - NeoGenomics: Decent Fundamentals, But Still Overvalued - Seeking Alpha
- 5 weeks ago - NeoGenomics to Participate in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - NeoGenomics, Inc (NEO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - NeoGenomics Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 2 months ago - NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 - Business Wire
- 2 months ago - NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan - Business Wire
- 2 months ago - NeoGenomics Announces Chief Executive Officer Succession - Business Wire